Company Profile
Headquartered in Frazer, PA Cephalon, Inc. (NASDAQ:CEPH) is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction.
A member of the Fortune 1000, Cephalon currently employs approximately 3,000 people in the United States and Europe.